Macquarie Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-751,788
| Closed | -$133M | – | 1213 |
|
|
2025
Q3 | $133M | Sell |
751,788
-174,766
| -19% | -$26M | 0.16% | 147 |
|
|
2025
Q2 | $105M | Buy |
926,554
+20,327
| +2% | +$2.17M | 0.13% | 215 |
|
|
2025
Q1 | $95.3M | Buy |
906,227
+21,847
| +2% | +$2.47M | 0.12% | 245 |
|
|
2024
Q4 | $94.8M | Sell |
884,380
-2,895
| -0.3% | -$327K | 0.12% | 248 |
|
|
2024
Q3 | $88.8M | Sell |
887,275
-79,277
| -8% | -$7.98M | 0.1% | 285 |
|
|
2024
Q2 | $81.4M | Sell |
966,552
-66,629
| -6% | -$5.3M | 0.09% | 279 |
|
|
2024
Q1 | $75.5M | Buy |
1,033,181
+45,827
| +5% | +$3.38M | 0.09% | 302 |
|
|
2023
Q4 | $70.5M | Sell |
987,354
-4,464
| -0.5% | -$263K | 0.08% | 340 |
|
|
2023
Q3 | $59.4M | Buy |
991,818
+154,648
| +18% | +$10.2M | 0.07% | 351 |
|
|
2023
Q2 | $60.4M | Buy |
837,170
+19,187
| +2% | +$1.44M | 0.07% | 367 |
|
|
2023
Q1 | $60.2M | Buy |
817,983
+17,387
| +2% | +$1.24M | 0.07% | 351 |
|
|
2022
Q4 | $53.5M | Sell |
800,596
-471,578
| -37% | -$30.7M | 0.06% | 421 |
|
|
2022
Q3 | $68.3M | Buy |
1,272,174
+15,544
| +1% | +$914K | 0.08% | 328 |
|
|
2022
Q2 | $69.9M | Buy |
1,256,630
+40,368
| +3% | +$2.29M | 0.08% | 348 |
|
|
2022
Q1 | $85.4K | Buy |
1,216,262
+214,437
| +21% | +$15.6M | 0.06% | 345 |
|
|
2021
Q4 | $96.5M | Sell |
1,001,825
-31,754
| -3% | -$2.93M | 0.08% | 314 |
|
|
2021
Q3 | $89.8M | Buy |
1,033,579
+81,881
| +9% | +$6.33M | 0.08% | 334 |
|
|
2021
Q2 | $77.9M | Buy |
951,698
+175,272
| +23% | +$14.6M | 0.06% | 382 |
|
|
2021
Q1 | $73.8M | Sell |
776,426
-657,743
| -46% | -$62.2M | 0.1% | 245 |
|
|
2020
Q4 | $89M | Buy |
1,434,169
+222,088
| +18% | +$12.7M | 0.13% | 172 |
|
|
2020
Q3 | $72.1M | Buy |
1,212,081
+22,570
| +2% | +$1.54M | 0.12% | 179 |
|
|
2020
Q2 | $83M | Buy |
1,189,511
+78,496
| +7% | +$4.98M | 0.14% | 148 |
|
|
2020
Q1 | $50.4M | Buy |
1,111,015
+86,273
| +8% | +$4.89M | 0.1% | 208 |
|
|
2019
Q4 | $66.7M | Buy |
1,024,742
+127,118
| +14% | +$8.49M | 0.1% | 225 |
|
|
2019
Q3 | $55.7M | Buy |
897,624
+54,707
| +6% | +$3.43M | 0.09% | 228 |
|
|
2019
Q2 | $60M | Buy |
842,917
+56,193
| +7% | +$4.14M | 0.1% | 209 |
|
|
2019
Q1 | $61.7M | Buy |
786,724
+82,066
| +12% | +$6.22M | 0.11% | 192 |
|
|
2018
Q4 | $59.7M | Buy |
704,658
+105,336
| +18% | +$11.2M | 0.12% | 170 |
|
|
2018
Q3 | $103M | Sell |
599,322
-37,250
| -6% | -$5.62M | 0.17% | 104 |
|
|
2018
Q2 | $82.3M | Buy |
636,572
+15,982
| +3% | +$1.78M | 0.14% | 134 |
|
|
2018
Q1 | $63.9M | Buy |
620,590
+29,527
| +5% | +$2.92M | 0.12% | 163 |
|
|
2017
Q4 | $50.5M | Sell |
591,063
-151,182
| -20% | -$13.1M | 0.09% | 214 |
|
|
2017
Q3 | $63M | Sell |
742,245
-12,861
| -2% | -$1.02M | 0.11% | 162 |
|
|
2017
Q2 | $57.2M | Buy |
755,106
+162,020
| +27% | +$11.3M | 0.1% | 162 |
|
|
2017
Q1 | $39.2M | Buy |
593,086
+65,435
| +12% | +$4.3M | 0.07% | 248 |
|
|
2016
Q4 | $33.4M | Buy |
527,651
+89,832
| +21% | +$5.67M | 0.06% | 278 |
|
|
2016
Q3 | $27.9M | Sell |
437,819
-465,084
| -52% | -$34.1M | 0.05% | 322 |
|
|
2016
Q2 | $67.2M | Buy |
902,903
+468,629
| +108% | +$34.8M | 0.07% | 240 |
|
|
2016
Q1 | $29M | Buy |
434,274
+61,807
| +17% | +$3.76M | 0.06% | 272 |
|
|
2015
Q4 | $25.2M | Sell |
372,467
-39,294
| -10% | -$2.43M | 0.05% | 292 |
|
|
2015
Q3 | $22M | Buy |
411,761
+62,236
| +18% | +$3.78M | 0.05% | 321 |
|
|
2015
Q2 | $22M | Sell |
349,525
-19,364
| -5% | -$1.06M | 0.04% | 346 |
|
|
2015
Q1 | $17.7M | Buy |
368,889
+149,502
| +68% | +$5.73M | 0.03% | 405 |
|
|
2014
Q4 | $7.28M | Buy |
219,387
+123,207
| +128% | +$4.01M | 0.02% | 607 |
|
|
2014
Q3 | $2.82M | Hold |
96,180
| – | – | 0.01% | 893 |
|
|
2014
Q2 | $3.74M | Hold |
96,180
| – | – | 0.01% | 803 |
|
|
2014
Q1 | $4.04M | Hold |
96,180
| – | – | 0.01% | 739 |
|
|
2013
Q4 | $3.16M | Sell |
96,180
-81,272
| -46% | -$2.65M | 0.01% | 787 |
|
|
2013
Q3 | $4.79M | Sell |
177,452
-22,923
| -11% | -$645K | 0.01% | 628 |
|
|
2013
Q2 | $4.68M | Buy |
+200,375
| New | +$3.6M | 0.01% | 611 |
|
Other funds holding LGND
NAMI
CC
SIMG
Macquarie Group's LGND Position: Q4 2025 in Review
Macquarie Group sold out of Ligand Pharmaceuticals (LGND) in Q4 2025, closing a stake of 751,788 shares — an estimated $133M sold.
Macquarie Group first reported a position in LGND in Q2 2013 and held it in 50 quarters. The position peaked at $133M in Q3 2025. 349 funds tracked by Wall St. Rank hold LGND as of Q4 2025.
- Macquarie Group reported no remaining Ligand Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Macquarie Group sold 751,788 Ligand Pharmaceuticals shares in Q4 2025, an estimated $133M.
- Macquarie Group first reported a position in Ligand Pharmaceuticals in Q2 2013 and held it in 50 quarters.
- Macquarie Group's Ligand Pharmaceuticals position peaked at $133M in Q3 2025.
- 349 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2025.
Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.